Literature DB >> 1404676

Peripheral vascular disease in heart transplant recipients.

D A Bull1, G C Hunter, J G Copeland, V M Bernhard, L J Rosado, K E McIntyre, G K Sethi, C W Putnam.   

Abstract

The improved longevity of heart transplant recipients demands heightened awareness of the long-term complications of the procedure. Between 1979 and 1990, 232 patients received 241 heart transplants at our institution. Accelerated coronary atherosclerosis occurred in 45 (19%) of the 232 patients, typically appearing within 2 years of transplantation, whereas peripheral vascular disease (PVD) appeared in 23 (10%) of the 232 patients, usually within 3 years of transplantation. In the patients with PVD, 13 had occlusive disease, nine had aneurysms, and one patient suffered a vertebral artery dissection. Accelerated coronary atherosclerosis afflicted 12 (52%) of the 23 patients affected by PVD (p < 0.05) and preceded the development of PVD in all 12. Logistic regression analysis revealed risk factors predictive of the development of PVD after transplantation to be a pretransplant history of ischemic cardiomyopathy and posttransplant hypertension and hypertriglyceridemia (p < 0.05), with the presence of more than one risk factor increasing the probability of development of PVD. Those patients thus identified as at risk should be closely monitored for the development of PVD. Aggressive medical management of hypertension and hyperlipidemia in this subpopulation may forestall or prevent the development of peripheral vascular disease after heart transplantation.

Entities:  

Mesh:

Year:  1992        PMID: 1404676

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  5 in total

1.  Effect of peripheral vascular disease on mortality in cardiac transplant recipients (from the United Network of Organ Sharing Database).

Authors:  Jorge Silva Enciso; Tomoko S Kato; Zhezhen Jin; Christine Chung; Jonathan Yang; Hiroo Takayama; Donna M Mancini; P Christian Schulze
Journal:  Am J Cardiol       Date:  2014-07-17       Impact factor: 2.778

2.  The incidence, morbidity, and mortality of surgical procedures after orthotopic heart transplantation.

Authors:  D S Bhatia; J C Bowen; S R Money; C H Van Meter; P M McFadden; J B Kot; A K Pridjian; H O Ventura; M R Mehra; F W Smart; J L Ochsner
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

Review 3.  Management of hyperlipidaemia associated with heart transplantation.

Authors:  Klaus Wenke
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  The impact of peripheral arterial disease on patients with mechanical circulatory support.

Authors:  Waqas Ullah; Yasar Sattar; Fahed Darmoch; Yasser Al-Khadra; Tanveer Mir; Rasikh Ajmal; Homam Moussa-Pacha; James Glazier; Abedelrahim Asfour; Delair Gardi; M Chadi Alraies
Journal:  Int J Cardiol Heart Vasc       Date:  2020-04-07

5.  Cardiac allograft vasculopathy in a long-term follow-up after heart transplantation: Role of remnant cholesterol in residual inflammation.

Authors:  Emyal Alyaydin; Christian Pogoda; Angelo Dell Aquila; Sven Martens; Izabela Tuleta; Holger Reinecke; Juergen R Sindermann
Journal:  Cardiol J       Date:  2022-04-04       Impact factor: 3.487

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.